DARA BioSciences Presented Positive Results of Its Phase I Study for DB959 at the American Diabetes Association Scientific Session
28. Juni 2011 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., June 28, 2011 (GLOBE NEWSWIRE) -- Today DARA BioSciences, Inc. (Nasdaq:DARA) announced the positive results of a randomized, placebo-controlled, double-blind, escalating single-dose...
DARA BioSciences to Present Positive Results of DB959 Phase I Study at the Upcoming 71st ADA Scientific Sessions
21. Juni 2011 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., June 21, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that an abstract has been accepted for presentation at the annual American Diabetes Association ("ADA")...
DARA BioSciences Secures Additional Intellectual Property
03. Mai 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., May 3, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) today announced the issuance of nine patents in the United States, Europe and other foreign jurisdictions relating...
DARA BioSciences Selected by the American Diabetes Association to Present Results of DB959 Phase I Study at the Upcoming 71st ADA Scientific Sessions
21. April 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 21, 2011 (GLOBE NEWSWIRE) -- Today DARA BioSciences, Inc. (Nasdaq:DARA) announced that an abstract has been accepted for presentation at the annual American Diabetes Association...
DARA BioSciences Reports SurgiVision has Received FDA Clearance for Its MRI-Compatible SmartFlow Cannula
19. April 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 19, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), reported today that SurgiVision, Inc. ("SVI"), a privately held company and a leader in interventional...
DARA BioSciences to Present at Three Financial Conferences in May
14. April 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 14, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the Company will present at three financial conference during May, 2011. Conference...
DARA BioSciences Reports That SurgiVision Has Completed a Commercial Alliance With Brainlab AG
12. April 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 12, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), reported today that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 a...
DARA BioSciences Files 2010 Annual Report and Issues Overview
07. April 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 7, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) a clinical biopharmaceutical drug development company, highlights a number of achievements disclosed in the...
DARA BioSciences Initiates a Phase Ib Clinical Study of DB959 for the Treatment of Type 2 Diabetes
05. April 2011 08:30 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., April 5, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that it has initiated a Phase Ib clinical study for DB959, its PPAR (peroxisome proliferator activated...
Report From Results of a Successful Phase II Study for DARA's KRN5500 at ADEPT
29. März 2011 08:30 ET
|
DARA BioSciences, Inc.
Is it the Medication or is it the Placebo Response That's Making You Feel Better?
Scientists Are Attempting to Understand the Phenomenon
RALEIGH, N.C., March 29, 2011 (GLOBE NEWSWIRE) -- DARA...